Antithrombotic post-operative treatment in recontructive arterial surgery

  • J. C. Baste
  • D. Midy


Conserving permeability of the different procedures in reconstructive arterial surgery is the main aim of the vascular surgeon. Yet in spite of care taken during these different procedures, thromboendarteriectomy, venous graft and synthetic or biosynthetic prosthesis have a rate of failure which is certainly variable but which may irreversibly compromise the clinical result. For example, although permeability five years later of an aortobifemoral prosthesis is about 85% in the literature, the distal femoropopliteal synthetic prosthesis is only 12% after four years in the multicentric study reported by VEITH [26].


Antithrombotic Treatment Peripheral Vascular Surgery Arterial Surgery European Stroke Prevention Study Synthetic Prosthesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Baxter BT, Bergman RT, Mc Carthy WJ et al. Prospective accessment of antithrombotic therapy following primary below knee prothetic by pass. American Society of Vascular Surgery, Los Angeles, 1990.Google Scholar
  2. 2.
    Bergqvist D. Pharmacologic prevention of graft occlusion. Acta Chir Scand (Suppl.) 529, 107–114, 1985. Google Scholar
  3. 3.
    Bergqvist D, Bergentz SE. The role of Dextran in severe ischemie chronic disease and arterial reconstructive surgery. A review. VASA 12, 213, 1983.Google Scholar
  4. 4.
    Birinyi LK, Logerfo FW. Intimal hyperplasia: evoluing concepts of pathophysiology and therapy. In: Quality Medical Publishing. Inc. St. Louis Missouri (Ed). Perspective in vascular surgery 2, 97–111, 1989. Google Scholar
  5. 5.
    Blakely JA, Pogoriler G. A prospective trial of Sulfinpyrazone after peripheral vascular surgery. Thromb Haemost 38, 238, 1977.Google Scholar
  6. 6.
    Bollinger A, Brunner H. Antiplatelet drugs improve the patency after femoro-popliteal endarterectomy. VASA 12, 172–178, 1983.Google Scholar
  7. 7.
    Clyne CA, Archer TJ, Atuhaire LK, Chant AD, Webster JH. Random control trial of short course Aspirine and Dipyridamole (Persantin) for femoro-distal graft. Br J Surg 74, 246–248, 1987.PubMedCrossRefGoogle Scholar
  8. 8.
    De Groote RD, Lynch TG, Jamil Z, Hobson RW. Carotid restenosis: long term non invasive follow up after carotid endarteriectomy. Stroke 18, 1031–1036, 1987.CrossRefGoogle Scholar
  9. 9.
    Flinn WR, Rohrer MJ, Yao ST. Improved long term patency of infragenicular polytetrafluoroethylene graft. J Vase Surg 7, 685–690, 1988.Google Scholar
  10. 10.
    Goldman M, McCollum L. A prospective randomized study to examin the effect of Aspirin and Dipyridamole on the patency of prosthetic femoro-popliteal grafts. Vase Surg 18, 217–220, 1984.Google Scholar
  11. 11.
    Goldman MD, Simpson D, Hawker RJ, Norcott HC, McCollum CN. Aspirin and Dipyridamole reduce platelet deposition on prothetic femoropopliteal grafts in man. Ann Surg 198, 713–716, 1983.PubMedCrossRefGoogle Scholar
  12. 12.
    Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med 104, 390–398, 1986.PubMedGoogle Scholar
  13. 13.
    Hass WK, Easton JD, Adam S. Jr et al for the ticlopidine aspirine stroke study group. A randomized trial comparing Ticlopidine hydrochloride with Aspirin for the prevention of stroke in high risk patients. N Engl J Med 321, 501–507, 1989.Google Scholar
  14. 14.
    Kolher TR, Kaufman JL, Kacoyangis G, Clowes A, Donaldson MC, Kelly E, Skillman J, Couch NP, Whittemore AD, Mannick JA et al. Effects of Aspirine and Dipyridamole on the patency of lower extremity by pass grafts. Surgery 96, 462–466, 1984.Google Scholar
  15. 15.
    Kretschmer G, Wenzle E, Piza F, Polterauer P, Ehringer H, Minar E, Schemper M. The influence of anticoagulant treatment as the probability of function in femoropopli-tealvein by pass surgery: analysis of clinical series (1970 to 1985) and interim evaluation of a controlled clinical trial. Surgery 3, 453–459, 1987.Google Scholar
  16. 16.
    Lepantalo MAURI. Adjuvant medical therapy to improve patency rate following reconstruction for atherosclerosis obliteration. Acta Chir Scand (suppl). 555, 51–58, 1990. Google Scholar
  17. 17.
    Levine AW, Bandyk DF, Bonier PH, Tonne JB. Lesions learned in adopting the in situ saphenous vein by pass. J Vase Surg 2, 145–153, 1985.Google Scholar
  18. 18.
    McCollum C, Alexander C, Kenchington G, Franks PJ, Greenhalgh R. Antiplatelets drugs in femoro-popliteal vein by passes: a multicenter trial. J Vase Surg 13, 150–161, 1991.CrossRefGoogle Scholar
  19. 19.
    McDaniel MD, Pearce WH, Yao JS, Rossi EC, Fahey VA, Green D, Flinn WR, Bergan JJ. Sequential changes in coagulation and platelet function following tibial by pass. J Vase Surg 1, 261–268 1984.Google Scholar
  20. 20.
    Recommandations du groupe dfétudes sur l’hémostase et la thrombose sur 1’utilisation des traitements antithrombotiques en pratique médicale courante. STV: John Libbey (Ed). Paris, numéro spécial, mai 1991.Google Scholar
  21. 21.
    Rutherford RB. Role of Antithrombotic drugs in maintening graft patency. In Current therapy in vascular surgery, 2nd edition, Ernst Stanley, BC Decker Inc. 1991. Google Scholar
  22. 22.
    Rutherford RB, Jones DN, Bergent SE et al. The efficacity of Dextran 40 in preventing early thrombosis following difficult lower extremity by-pass. J Vase Surg 1, 765–773, 1984.Google Scholar
  23. 23.
    Shionoya S, Sakukai T. Influence de la Ticlopidine sur les résultats de la chirurgie arterielle périphérique — Etude prospective multicentrique de 3 ans. STV (Suppl) 2(4), 12–16, 1990. Google Scholar
  24. 24.
    The European stroke prevention study — ESPS —Principal end point. Lancet 2, 1351–1354, 1987. Google Scholar
  25. 25.
    U.K.T.I.A. Study group (United Kingdom transcent Ischaemic Attack). Aspirin trials: Interim results. Brit Med J 296, 316–320, 1988. CrossRefGoogle Scholar
  26. 26.
    Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA, Towne JB, Bernhard VM, Bonier P, Flinn WR et al. Six years prospective multicenter randomized comparaison of autologous saphenous vein and expanded polytetrafluoroethylene graft in infrainguinal reconstructions. J Vase Surg 3, 104–113, 1986.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1994

Authors and Affiliations

  • J. C. Baste
  • D. Midy

There are no affiliations available

Personalised recommendations